Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Evaluating the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy in Patients Treated With Oxaliplatin or Paclitaxel

NCT07399561 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT07399561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07399561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Evaluating the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy in Patients Treated With Oxaliplatin or Paclitaxel
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 3, 2026
Completion date
December 31, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxaliplatin induced peripheral neuropathy in cancer patients, paclitaxel induced neuropathy, peripheral neuropathy, secondary to drugs or chemicals